Champions Oncology, Inc. (CSBR)
4.99
+0.02
(+0.40%)
USD |
NASDAQ |
Oct 06, 16:00
4.99
0.00 (0.00%)
After-Hours: 19:07
Champions Oncology Cash from Investing (Quarterly) : -0.055M for July 31, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.055M |
| April 30, 2026 | -0.238M |
| January 31, 2026 | -0.014M |
| October 31, 2025 | -0.242M |
| July 31, 2025 | -0.046M |
| April 30, 2025 | -0.253M |
| January 31, 2025 | -0.042M |
| October 31, 2024 | -0.094M |
| July 31, 2024 | 0.00 |
| April 30, 2024 | 0.111M |
| January 31, 2024 | -0.126M |
| October 31, 2023 | -0.153M |
| July 31, 2023 | -0.668M |
| April 30, 2023 | -0.76M |
| January 31, 2023 | -0.754M |
| October 31, 2022 | -0.604M |
| July 31, 2022 | -0.754M |
| April 30, 2022 | -0.506M |
| January 31, 2022 | -0.405M |
| October 31, 2021 | -0.566M |
| July 31, 2021 | -0.907M |
| April 30, 2021 | -0.834M |
| January 31, 2021 | -1.203M |
| October 31, 2020 | -0.506M |
| July 31, 2020 | -0.626M |
| Date | Value |
|---|---|
| April 30, 2020 | -1.527M |
| January 31, 2020 | -0.171M |
| October 31, 2019 | 0.227M |
| July 31, 2019 | -0.749M |
| April 30, 2019 | -0.141M |
| January 31, 2019 | -0.207M |
| October 31, 2018 | -0.275M |
| July 31, 2018 | -0.211M |
| April 30, 2018 | -0.209M |
| January 31, 2018 | -0.075M |
| October 31, 2017 | -0.032M |
| July 31, 2017 | -0.91M |
| April 30, 2017 | -0.585M |
| January 31, 2017 | -0.151M |
| October 31, 2016 | -0.013M |
| July 31, 2016 | -0.017M |
| April 30, 2016 | -0.146M |
| January 31, 2016 | -0.132M |
| October 31, 2015 | -0.015M |
| July 31, 2015 | -0.029M |
| April 30, 2015 | -0.03M |
| January 31, 2015 | -0.013M |
| October 31, 2014 | -0.038M |
| July 31, 2014 | -0.033M |
| April 30, 2014 | -0.07M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Medpace Holdings, Inc. | -23.88M |
| Avantor, Inc. | -37.30M |
| Personalis, Inc. | 38.16M |
| Adaptive Biotechnologies Corp. | -43.48M |
| 10X Genomics, Inc. | -7.735M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.492M |
| Cash from Financing (Quarterly) | 0.033M |
| Free Cash Flow | -6.137M |
| Free Cash Flow Per Share (Quarterly) | -0.0394 |
| Free Cash Flow to Equity (Quarterly) | -6.919M |
| Free Cash Flow to Firm (Quarterly) | -0.547M |
| Free Cash Flow Yield | -8.76% |